Quick Answer
RESMED INC reported Diluted EPS of $9.51 per share for fiscal year 2025.
RESMED INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $9.51 | +37.4% |
| 2024 | $6.92 | +13.6% |
| 2023 | $6.09 | +14.9% |
| 2022 | $5.30 | +63.6% |
| 2021 | $3.24 | -24.1% |
| 2020 | $4.27 | +52.5% |
| 2019 | $2.80 | +27.9% |
| 2018 | $2.19 | -8.8% |
| 2017 | $2.40 | -3.6% |
| 2016 | $2.49 | +0.8% |
| 2015 | $2.47 | +3.3% |
| 2014 | $2.39 | +13.8% |
| 2013 | $2.10 | +22.8% |
| 2012 | $1.71 | +18.8% |
| 2011 | $1.44 | +17.1% |
| 2010 | $1.23 | +29.5% |
| 2009 | $0.95 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $2.68 | +14.5% | +13.1% |
| September 30, 2025 | $2.37 | +12.3% | -4.4% |
| March 31, 2025 | $2.48 | +21.6% | +6.0% |
| December 31, 2024 | $2.34 | +64.8% | +10.9% |
| September 30, 2024 | $2.11 | +41.6% | +3.4% |
| March 31, 2024 | $2.04 | +29.1% | +43.7% |
| December 31, 2023 | $1.42 | -7.2% | -4.7% |
| September 30, 2023 | $1.49 | +4.2% | -5.7% |
- RESMED INC showed an increase of +37.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, RESMED INC’s diluted eps has grown by 901.1% (from $0.95 per share to $9.51 per share).
- The most recent figure is from RESMED INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: